Medical silicone supplier FMI launched the FMI iQ, a system which links real-time production data with performance metrics, quality data, employee training, and continuous improvement and risk management tools. The FMI iQ system was created to harness and integrate the power of real-time data during production to help ensure zero defects in silicone molding for medical devices.
FMI iQ uses a custom portal to allow FMI’s manufacturing, quality, and engineering staff to have instant access to three critical components of quality in silicone molding:
- Robust Quality Data Collection – which is collected and reported in real time, during silicone manufacturing, along with material tracking data, and regular reports on key performance indicators such as scrap, defects and trends
- Employee Performance and Resources – including the individual’s quality data on all silicone molded parts produced and experience on different types of equipment, as well as company policies and procedures, safety programs, and upcoming training programs, which employees can access to achieve higher levels of expertise
- Continuous Improvement and Risk Management – which outlines how risk is to be managed for every silicone molding project, including integrated control plans, PFMEAs, risk profiles for each part and critical to functionality indices, as well pertinent regulations
“FMI has made a major investment to ensure the highest quality in medical silicone molding by integrating individual department activities into one interface,” said Harold Sant, Vice President of Operations for FMI. “While we have been using these systems independently for many years, FMI iQ for the first time brings together all of our quality data and resources, which allows us to respond immediately to any concerns, as well as surpass our customers’ requirements for quality reporting and audits.”